Literature DB >> 14528548

Psychosocial correlates of cancer relapse and survival: a literature review.

M F De Boer1, R M Ryckman, J F Pruyn, H W Van den Borne.   

Abstract

This article reviews literature on the psychosocial correlates of cancer relapse and survival from 1979 through 1995. The factors studied were structured according to a theoretical model of coping with cancer. Reviewed studies have shown that factors most frequently evaluated were depression, anxiety, hopelessness/helplessness, hostility, marital status and social involvement. Mainly inconsistent results were found. The strongest evidence for a relationship between psychosocial variables and prognosis was found for social involvement/social support; in 7 of 15 studies a positive relationship was demonstrated, while no negative associations were found. Coping styles e.g., fighting spirit and stoic acceptance, and severe/stressful life events were found to have no conclusive influence on the length of survival. Important determinants of the coping model, such as uncertainty and information given by the specialist were not studied as possible predictors of survival and/or relapse free period. Among the factors that showed no correlation at all was multidimensional health locus of control. For the inconsistent findings, a considerable number of methodologic shortcomings with respect to study design, sample size, measure and statistical analysis are enumerated.

Entities:  

Mesh:

Year:  1999        PMID: 14528548     DOI: 10.1016/s0738-3991(99)00029-4

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  15 in total

1.  Transitoriness in cancer patients: a cross-sectional survey of lung and gastrointestinal cancer patients.

Authors:  Maya Shaha; Vinciya Pandian; Michael A Choti; Eden Stotsky; Joseph M Herman; Yasmin Khan; Carol Libonati; Timothy M Pawlik; Richard D Schulick; Anne E Belcher
Journal:  Support Care Cancer       Date:  2010-02-21       Impact factor: 3.603

2.  Effect of different forms of information produced for cancer patients on their use of the information, social support, and anxiety: randomised trial.

Authors:  R B Jones; J Pearson; A J Cawsey; D Bental; A Barrett; J White; C A White; W H Gilmour
Journal:  BMJ       Date:  2006-04-05

3.  Marital status and stage at diagnosis of cutaneous melanoma: results from the Surveillance Epidemiology and End Results (SEER) program, 1973-2006.

Authors:  John M McLaughlin; James L Fisher; Electra D Paskett
Journal:  Cancer       Date:  2010-11-10       Impact factor: 6.860

4.  Social support and survival in patients with acute myeloid leukaemia.

Authors:  Martin Pinquart; Klaus Höffken; Rainer K Silbereisen; Ulrich Wedding
Journal:  Support Care Cancer       Date:  2006-09-27       Impact factor: 3.603

5.  Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area.

Authors:  Margaret Wrensch; Terri Rice; Rei Miike; Alex McMillan; Kathleen R Lamborn; Kenneth Aldape; Michael D Prados
Journal:  Neuro Oncol       Date:  2006-01       Impact factor: 12.300

Review 6.  Associations of social networks with cancer mortality: a meta-analysis.

Authors:  Martin Pinquart; Paul R Duberstein
Journal:  Crit Rev Oncol Hematol       Date:  2009-07-14       Impact factor: 6.312

7.  Perceptions of anxiety in lung cancer patients and their support network.

Authors:  D Buchanan; R Milroy; L Baker; A M Thompson; P A Levack
Journal:  Support Care Cancer       Date:  2009-04-07       Impact factor: 3.603

8.  [Geriatric assessment prior to oncological therapy].

Authors:  U Wedding
Journal:  Urologe A       Date:  2013-06       Impact factor: 0.639

9.  Social integration and survival after diagnosis of colorectal cancer.

Authors:  Elizabeth A Sarma; Ichiro Kawachi; Elizabeth M Poole; Shelley S Tworoger; Edward L Giovannucci; Charles S Fuchs; Ying Bao
Journal:  Cancer       Date:  2017-11-21       Impact factor: 6.860

Review 10.  [Systemic cancer treatment in geriatric patients].

Authors:  J Hess
Journal:  Urologe A       Date:  2015-12       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.